Form 4: MapLight Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
James Woodruff Lillie, Chief Scientific Officer of MapLight Therapeutics, Inc., sold 11,513 shares of common stock on October 15, 2026 for $8.08 per share.
Summary
- Open-market sale: disposed of 11,513 Voting Common Stock at $8.08 ($93,025) on October 15, 2026; holds 198,597 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $93,025 of stock on the open market.
Insider Transactions
James Woodruff Lillie — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Open-market sale | Voting Common Stock | 11,513 | $8 | $93.0K | 198,597 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Open-market sale (11,513 shares) |
Keywords
insider transaction, Form 4, MPLT, MapLight Therapeutics, Inc., bearish, James Woodruff Lillie
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.